LOXO-435 (LY3866288)

LOXO-435 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LOXO-435 (LY3866288), covering 2026-04-20 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3 [Phase 1]

See pricing